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A Bovine Herpesvirus 1 Protein Expressed in Latently Infected
Neurons (ORF2) Promotes Neurite Sprouting in the Presence of
Activated Notch1 or Notch3
Devis Sinani, Leticia Frizzo da Silva, Clinton Jones
School of Veterinary Medicine and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska—Lincoln, Lincoln, Nebraska, USA
Bovine herpesvirus 1 (BHV-1) infection induces clinical symptoms in the upper respiratory tract, inhibits immune responses,
and can lead to life-threatening secondary bacterial infections. Following acute infection, BHV-1 establishes latency in sensory
neurons within trigeminal ganglia, but stress can induce reactivation from latency. The latency-related (LR) RNA is the only viral
transcript abundantly expressed in latently infected sensory neurons. An LRmutant virus with stop codons at the amino termi-
nus of the first open reading frame (ORF) in the LR gene (ORF2) is not reactivated from latency, in part because it induces higher
levels of apoptosis in infected neurons. ORF2 inhibits apoptosis in transiently transfected cells, suggesting that it plays a crucial
role in the latency-reactivation cycle. ORF2 also interacts with Notch1 or Notch3 and inhibits its ability to trans activate certain
viral promoters. Notch3 RNA and protein levels are increased during reactivation from latency, suggesting that Notch may pro-
mote reactivation. Activated Notch signaling interferes with neuronal differentiation, in part because neurite and axon genera-
tion is blocked. In this study, we demonstrated that ORF2 promotes neurite formation in mouse neuroblastoma cells overex-
pressing Notch1 or Notch3. ORF2 also interfered with Notch-mediated trans activation of the promoter that regulates the
expression of Hairy Enhancer of Split 5, an inhibitor of neurite formation. Additional studies provided evidence that ORF2 pro-
motes the degradation of Notch3, but not that of Notch1, in a proteasome-dependent manner. In summary, these studies suggest
that ORF2 promotes a mature neuronal phenotype that enhances the survival of infected neurons and consequently increases the
pool of latently infected neurons.
Bovine herpesvirus 1 (BHV-1) is a significant viral pathogen ofcattle (1) that suppresses immune responses. BHV-1, because
of its immunosuppressive properties, can initiate a polymicrobial
respiratory tract disease commonly referred to as bovine respira-
tory disease complex (reviewed in references 2–4). As for other
Alphaherpesvirinae subfamily members, the primary site for
BHV-1 latency is sensory neurons within trigeminal ganglia (TG).
Lytic-cycle viral gene expression (5) and infectious virus (6) are
detected in TG during acute infection, but latency is subsequently
established. Increased corticosteroid levels, as a result of stress, can
initiate BHV-1 reactivation from latency (3). Administration of
the synthetic corticosteroid dexamethasone (DEX) to calves or
rabbits latently infected with BHV-1 reproducibly leads to reacti-
vation from latency and virus shedding (6–11). Induction of lytic-
cycle viral gene expression is consistently detected in TG neurons
of calves latently infected with BHV-1 following DEX treatment
(11–13).
The BHV-1 latency-related (LR) RNA is the only abundant
viral transcript expressed in latently infected sensory neurons (14,
15). The LR gene contains twomajor open reading frames (ORFs),
ORF2 and ORF1, and two reading frames that lack an initiating
methionine (RF-C and RF-B) (16). Two microRNAs encoded
within the LR gene inhibit BHV-1 infected cell protein 0 (bICP0)
expression (17) and promote cell survival (18). A mutant BHV-1
strain with three stop codons at the N terminus of ORF2 (LR
mutant virus) does not express detectable levels of ORF2 or RF-C
(19) but expresses reduced levels of ORF1 during the productive
infection of cultured cells (20). The LR mutant virus grows less
efficiently in the ocular cavity or TG but is not reactivated from
latency following DEX treatment (6, 21), suggesting that expres-
sion of LR proteins is required for the latency-reactivation cycle in
cattle. During the establishment of latency, the LR mutant virus
induces higher levels of apoptosis in TGneurons of infected calves
(22) and plasmids with the same stop codon mutations exhibit
little or no antiapoptosis activity (23, 24).
ORF2 protein expression, in the absence of other viral genes,
inhibits apoptosis in transiently transfected cells (25), suggesting
that ORF2 is a dominant function encoded by the LR gene. ORF2
also interacts with the intracellular domain (ICD) of Notch1
and Notch3, components of the Notch signaling pathway (26).
Notch1, but not Notch3, enhances productive BHV-1 infection
plus trans activates the BHV-1 immediate-early transcription unit
1 (IEtu1) and bICP0 early promoters, whereas both Notch1 and
Notch3 trans activate the late BHV-1 glycoprotein C (gC) pro-
moter. ORF2 interferes with the ability of Notch1 to trans activate
the bICP0 early promoter and Notch1- or Notch3-mediated acti-
vation of the gC promoter (26), suggesting that this function pro-
motes the establishment and/or maintenance of latency.
Notch receptors (Notch1 to Notch4) are membrane-tethered
transcription factors that regulate the differentiation and develop-
ment of nearly all cell types (reviewed in references 27–30). When
the Notch receptor is engaged by one of its five transmembrane
ligands (Jagged1, Jagged2, Delta-like1, Delta-like3, and Delta-
like4), the Notch ICD is cleaved by specific proteases and the
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Notch ICD translocates to the nucleus and is considered to be
“active.” The Notch ICD interacts with members of the CSL fam-
ily of transcriptional repressors, CBF1, Su(H), or Lag1 (also re-
ferred to as RBPj for mammalians), and mastermind (MAML).
The Notch-CSL-MAML complex binds to specific DNA se-
quences, RNA polymerase II coactivators are recruited to the
Notch-CSL-MAML complex, and consequently transcription oc-
curs (27, 29). In the absence of an activatedNotch familymember,
a CSL complex, which includes repressor proteins, inhibits tran-
scription. Activation of Notch signaling in postmitotic neurons or
neuroblastoma cells inhibits neurite sprouting (31–34) and axon re-
pair (35), which can lead to neuronal degeneration and apoptosis
(36–38). Conversely, neurite sprouting correlates with the regenera-
tion of damaged axons and dendrites (35). During neural develop-
ment, activation of Notch is crucial for the maintenance of neural
progenitors and suppression of neuronal differentiation (30, 39).
Consequently, disruption ofNotch1 inmice leads to the depletion of
neural progenitor cells (40, 41).
In this study, we found that Notch1 or Notch3 inhibits neurite
formation in serum-arrested mouse neuroblastoma (Neuro-2A)
cells.WhenORF2 is cotransfectedwithNotch1 orNotch3, neurite
formation is restored, suggesting that ORF2 impairs Notch-de-
pendent signaling. ORF2 also interfered with Notch-mediated
trans activation of the promoter that encodes Hairy Enhancer of
Split 5 (HES5), which interferes with neurite formation when
overexpressed. Certain transposonmutant constructs and the nu-
clear localization signal in ORF2 were important for inhibition of
neurite formation in the presence of Notch. Mutation of five con-
sensus protein kinase A and/or protein kinase C phosphorylation
sites within ORF2 did not affect the ability of ORF2 to stimulate
neurite formation.We suggest that the ability ofORF2 to promote
neurite formation in the presence of activated Notch promotes
normal neural functions following infection.
MATERIALS AND METHODS
Cells. Murine neuroblastoma (Neuro-2A) cells were grown in Earle’s
modified Eagle’s medium (EMEM) supplemented with 5% fetal calf se-
rum (FCS), penicillin (10 U/ml), and streptomycin (100 g/ml).
Plasmids and transient transfections.TheORF2wild-type (WT) and
mutant constructs were cloned into the pCMV-Tag-2A or pCMV-Tag-2B
vector (Stratagene, La Jolla, CA) downstream of a Flag epitope by using
BamHI-HindIII restriction enzymes as previously described (25). In
pCMV-TAG-2A, ORF2 is cloned as a single nucleotide frameshift, which
expresses the mRNA but not the protein (25). Notch1 and Notch3 ICD
constructs were kindly provided by U. Lendahl, Karolinska Institute,
Stockholm, Sweden (42). A plasmid containing the firefly luciferase gene
downstreamof theHES5 promoterwas a kind gift from (R. Kopan,Wash-
ington University, St. Louis, MO). All plasmids were transfected into
Neuro-2A cells in 60-mm dishes as indicated, by using TransIT Neural
(MIR2145; Mirus) according to the manufacturer’s instructions.
Immunohistochemistry analysis. Immunohistochemistry analysis
was performed by using an ABC kit (Vector Laboratories) according to
themanufacturer’s specifications. TGwere collected from calves that were
mock infected, latently infected (at least 60 days after initial infection), or
latently infected and treatedwithDEX to induce reactivation from latency
as previously described (43). TG were fixed with formalin and then em-
bedded in paraffin. Thin sections (4 to 5m)of TGwere cut andmounted
on glass slides. Slides were first incubated at 65°C for 20 min and then
washed twice in xylene for 10 min each time, twice in 100% ethanol
(EtOH) for 5 min, once in 90% EtOH for 5 min, once in 70% EtOH for 5
min, twice in distilled H2O for 5min, and three times in 1 Tris-buffered
saline (TBS) for 5 min each time. To block any endogenous peroxidase
activity, sections were incubated in hydrogen peroxide (0.03% in phos-
phate-buffered saline [PBS], pH 7.4) for 20 min at room temperature.
Tissue sectionswere thenwashed three times in 1TBS for 5min at room
temperature, followed by digestion with proteinase K (S3020; Dako) for
20min at 37°C. Tissue sections were then blocked with 5% normal serum
diluted in 1 TBS containing 0.25% bovine serum albumin for 45 min at
room temperature in a humidified chamber. Slides were incubated with
Notch1 (3268S; Cell Signaling), Notch3 (SC-5593; Santa Cruz Biotech-
nology), or ORF2 rabbit polyclonal antibody at a 1:500 dilution overnight
in a humidified chamber at 4°C. The next day, slides were washed in 1
TBS and incubated in biotinylated goat anti-rabbit IgG (PK-6101; Vector
Laboratories) for 30 min at room temperature in a humidified chamber.
Avidin-biotinylated enzyme complexwas added to the slides for 30min of
incubation at room temperature. After three washes in 1 TBS, slides
were incubated with freshly prepared substrate (SK-4800; Vector Labora-
tories), rinsed with distilled water, and counterstained with hematoxylin
for 1min. Thin sections frommock-infected calveswere used as a negative
control.
Neurite formation assay.Neuro-2A cells grown in 60-mmplateswere
cotransfected with a human cytomegalovirus promoter plasmid express-
ing the Notch1 or Notch3 ICD (1 g DNA), a pCMV-Tag plasmid ex-
pressing Flag-tagged ORF2 or mutant ORF2 constructs (1 g DNA), and
a pCMV--Gal plasmid (1 g DNA). To induce neurite sprouting, 24 h
after transfection, cells were seeded into new plates at a low density of
2,000/cm2 and starved in medium with 0.5% serum for 3 days. Cells were
then fixed and stained, and a-galactosidase (-Gal) assaywas performed
as previously described (44). The percentage of cells with -Gal neurites
was calculated by dividing the number of -Gal cells with a neurite
length at least twice the diameter of the cell by the total number of-Gal
cells. The results are an average of three independent experiments.
Dual-luciferase reporter assay.Neuro-2A cells (8 105) were seeded
into 60-mm dishes containing EMEM with 10% FCS at 24 h prior to
transfection. Two hours before transfection, the medium was replaced
with fresh EMEM containing 0.5% FCS to lower the basal levels of HES5
promoter activity. Cells were cotransfected with a plasmid containing the
firefly luciferase gene downstream of the HES5 promoter (1 g DNA), a
plasmid encoding Renilla luciferase under the control of the herpesvirus
thymidine kinase (TK) promoter (50 ng), the indicatedNotch1 orNotch3
plasmid (1gDNA), and aWTormutantORF2 plasmid (1gDNA). To
maintain equal plasmid amounts in the transfection mixtures, the empty
expression vector was added as needed. Forty hours after transfection,
cells were harvested and protein extracts were subjected to a dual-
luciferase assay by using a commercially available kit (E1910; Promega)
according to the manufacturer’s instructions. Luminescence was mea-
sured by using a GloMax 20/20 luminometer (E5331; Promega).
Western blot assay. Neuro-2A cells in 60-mm plates were cotrans-
fected with a plasmid expressing the Notch3 ICD (2 g DNA) and the
designated ORF2 plasmids (2 g DNA), and cultures were washed once
with 1 PBS and then suspended in radioimmunoprecipitation assay
buffer (50 mM Tris-HCl [pH 8], 150 mM NaCl, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate [SDS], 1% Triton X-100, protease
inhibitor) and incubated at 4°C for 30 min with rotation. Lysate was
cleared by centrifugation at 14,000 rpm for 10min. Protein concentration
was measured by using the standard Bradford assay. Equal amounts of
protein were boiled in Laemmli sample buffer for 5 min and separated on
a 10% SDS-polyacrylamide gel. A mouse anti-Flag antibody (F1804;
Sigma) at 1:500 was used to detect WT and mutant ORF2, while Notch3
was detected by using a rabbit anti-Notch3 antibody (SC-5593; Santa
Cruz Biotechnology). A goat anti--actin antibody (SC-1616; Santa Cruz
Biotechnology) was used as a loading control. To block protein syn-
thesis, 40 h after transfection, cells were treated with cycloheximide
(CHX; 100 M) at the indicated time points. To block proteasome
activity, cells were treated with 15 M lactacystin (70980; Cayman
Chemical) 10 h prior to CHX treatment. Cells were subsequently pro-
cessed for Western blot analysis.
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RESULTS
Expression of Notch andORF2 in TG during the latency-reacti-
vation transition. A previous study demonstrated that Notch3
RNA levels were increased in TG during DEX-induced reactiva-
tion from latency (26). Immunohistochemistry analysis was used
to determine if Notch protein expression occurs in sensory neu-
rons within TG during DEX-induced reactivation from latency.
Notch3-positive neurons were detected in a subset of TG neurons
at 3 or 6 h afterDEX treatment (Fig. 1A). Even at 90min afterDEX
treatment, Notch3-positive neurons could be detected (data not
shown). Conversely, Notch3-positive neurons were not readily
detected in mock-infected TG sections, in latently infected TG, or
at 24 h after DEX treatment (data not shown). Although Notch1
was detected in TG after DEX treatment (Fig. 1B), in general,
fewer neurons were positive and the signal was weak.
As a comparison, we examinedORF2 protein expression in TG
samples prior to and during the early stages of DEX-induced re-
activation from latency. In contrast to TG from mock-infected
calves, ORF2 was readily detected in TG sections of latently in-
fected calves (Fig. 1C). Since LR RNA expression is reduced dur-
ing DEX-induced reactivation from latency (11), it was not sur-
prising to find that the number of ORF2-positive neurons
appeared to go down at 6 and 24 h after DEX treatment (Fig. 1C).
In summary, these results provide evidence that Notch3, but not
ORF2, protein expression was induced by DEX in TG neurons.
ORF2antagonizesNotch-mediated inhibitionofneurite for-
mation. ORF2 stably interacts with Notch3 or Notch1, and these
interactions impair the ability of Notch to stimulate viral gene
expression and productive infection (26, 44). Although these
studies indicated that ORF2 interferes with the ability of Notch
family members to stimulate viral promoters and productive in-
fection, they did not address whether ORF2 influences activated
Notch in the context of known cellular functions. ActivatedNotch
signaling in neurons inhibits neurite sprouting (31–34) and axon
repair (35), which can result in neuronal cell death (36, 37). Con-
versely, neurite sprouting is synonymous with the regeneration of
damaged axons and dendrites (35). Althoughmany of these stud-
ies were performedwith neurons derived from the central nervous
system (CNS) or in the CNS itself, activated Notch also interferes
with neuronal differentiation in the ophthalmic branch of TG
(45).
To test whether ORF2 affects Notch functions in mammalian
FIG 1 Expression of Notch and ORF2 in TG. TGwere collected from calves that were mock infected, latently infected (at least 60 days postinfection), or latently
infected and treated with DEX at the indicated times (hours [H]) after DEX treatment to induce reactivation from latency. Thin sections were cut and subjected
to immunohistochemistry analysis with antibodies that specifically recognize Notch3 (A), Notch1 (B), or ORF2 (C) as described in Materials and Methods.
Biotinylated goat anti-rabbit IgG was used as a secondary antibody. Thin sections from mock-infected calves were used as a negative control. Arrows indicate
positive neurons.
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cells, mouse neuroblastoma cells (Neuro-2A) were transfected
with a plasmid that expresses Notch1 or Notch3 and the effect
ORF2 has on neurite formation was examined. For all of these
studies, the plasmids used to express Notch1 or Notch3 express
only the Notch ICD, these proteins are constitutively active, and
they function regardless of the Notch ligand or receptor status of
surrounding cells. When Neuro-2A cells were transfected with a
LacZ expression vector and growth factors were removed, -Gal
neurites were readily detected when cells were seeded at low den-
sity and then serum starved for 3 days (Fig. 2A, control panel). As
expected (32, 33), Notch1 or Notch3 overexpression inhibited
neurite formation after growth factor withdrawal (Notch1 or
Notch3 panels). When ORF2 was cotransfected with the Notch1
or Notch3 expression plasmid, -Gal Neuro-2A cells with ex-
tended neurites were frequently detected. We detected -Gal
Neuro-2A cells with extended neurites that were touching each
other after cotransfection with Notch1 or Notch3 and ORF2, as
well as single -Gal Neuro-2A cells. Approximately half of the
-Gal cells consistently sprouted neurites when Neuro-2A cells
were cotransfected with Notch1 or Notch3 and ORF2, which was
a significantly larger proportion than that ofNeuro-2A cells trans-
fected with Notch1 or Notch3 and the empty expression vector
(Fig. 2B).
To localize domains in ORF2 that interfere with Notch inhibi-
tion of neurite formation, the neurite formation assay was per-
formed with Neuro-2A cells and a panel of mutant constructs
previously described (44) (schematics of the respective mutant
ORF2 constructs are shown in Fig. 3A and B). Compared to WT
ORF2, four transposon mutant constructs, ORF2-95, ORF2-134,
ORF2-240, and ORF2-271, did not restore neurite formation as
efficiently (Fig. 4A and B). A significant difference between the
four transposon mutant constructs and WT ORF2 was observed
(P  0.05). Since ORF2-95, unlike the other transposon mutant
constructs, expresses lower protein levels in Neuro-2A cells than
WT ORF2 does (44), it is difficult to distinguish whether its im-
paired functionwas due to protein expression levels or if an essen-
tial inhibitory domain was disrupted. The remainder of the trans-
poson mutant constructs restored neurite formation similar to
that seenwithWTORF2, regardless of whether they were cotrans-
fected with Notch1 or Notch3 (Fig. 4A and B). The phosphoryla-
tion mutant constructs ORF2-P and ORF2-AP, but not ORF2-
NLS, promoted neurite formation in the presence of Notch1 or
Notch3 with an efficiency similar to that of WTORF2, suggesting
that nuclear localization, but not the phosphorylation status of
ORF2, was important. In conclusion, these studies provided evi-
dence that ORF2 interfered with activated Notch1 or Notch3 sig-
naling and promoted neurite formation in Neuro-2A cells. Cer-
tain transposon mutant constructs and nuclear localization
signals within ORF2 were important for this function.
ORF2 inhibits activation of the HES5 promoter, a down-
stream target of Notch.To further examine the ability of ORF2 to
interferewithNotch signaling, we testedwhetherORF2 influences
the Notch-mediated trans activation of the HES5 promoter. The
HES family of transcription factors contains basic helix-loop-
helix domains that generally repress transcription, and HES pro-
moters are trans activated by Notch (reviewed in references 27–29
and 46). SinceHes1 andHes5 are transcription factors that inhibit
neuronal differentiation (47), examination of the effect of ORF2
FIG 2 ORF2 antagonizes Notch inhibition of neurite formation. (A) Neuro-2A cells were cotransfected with a plasmid expressing the Notch1 or Notch3 ICD,
a plasmid expressingORF2, and a plasmid expressing the LacZ gene (transfection control). To induce neurite sprouting, 24 h after transfection, cells were seeded
into new plates at a low density (2,000/cm2) and then starved in medium with 0.5% serum for 3 days. Cells were then fixed, and -Gal cells were identified as
described inMaterials andMethods. (B) The percentage of-Gal cells containing neurites was calculated by dividing the number of-Gal cells with a neurite
length at least twice the diameter of the cell by the total number of-Gal cells. The average of at least three independent experiments is shownwith the respective
standard deviation. An asterisk denotes significant differences (P 0.05) in -GalNeuro-2A cells containing neurites following cotransfection with the ORF2
reporter and a Notch1 or Notch3 expression plasmid relative to -Gal Neuro-2A cells with neurites following transfection with a plasmid expressing Notch1
or Notch3 plus the empty vector, as determined by the Student t test.
Sinani et al.
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on HES5 promoter activity is relevant to the finding that ORF2
promoted neurite formation in the presence ofNotch1 orNotch3.
A dual-luciferase assay was performed with a reporter plasmid
that contains theHES5 promoter upstream of the firefly luciferase
gene. Increasing amounts of Notch1 (Fig. 5A) and Notch3
(Fig. 5B) increased HES5 promoter activity in a dose-dependent
fashion. In general, Notch1 is a more efficient trans activator than
Notch3 (42), which was consistent with the results obtained with
Neuro-2A cells.
Neuro-2A cells were cotransfected with plasmids expressing
ORF2, Notch1, or Notch3; the HES5 promoter and luciferase ac-
tivities were measured to test whether ORF2 influenced trans ac-
tivation of the HES5 promoter. ORF2 consistently inhibited
Notch1-mediated trans activation of the HES5 promoter by
FIG 3 Schematics of theORF2 andmutantORF2 constructs used for this study. (A) Amino acid sequence of ORF2. The nuclear localization signal (underlined),
15 putative phosphorylation sites (gray-shaded amino acids) and five consensus protein kinase A and/or protein kinase C phosphorylation sites (gray-shaded
amino acids with white lettering) are shown. The plus signs denote every 10th amino acid in ORF2. (B) ORF2 coding sequences (BamHI-SalI) were cloned into
the pUC57 vector, and transposon linker insertion reactions were performed as previously described (44). Vertical lines with the respective numbers indicate the
nucleotide position of the respective transposon insertions. The relative position of the consensus nuclear localization signal (NLS) is denoted by the white
rectangle.
FIG 4 Localization of ORF2 sequences necessary to inhibit neurite formation
in the presence of Notch1 or Notch3. Neuro-2A cells were cotransfected with
a plasmid expressing theNotch1 (A), or Notch3 (B) ICD, a plasmid expressing
WTORF2 or the designatedmutantORF2 construct, and a plasmid expressing
LacZ.Neurite formationwasmeasured as described in the legend to Fig. 2 after
serum starvation and the identification of -GalNeuro-2A cells. The results
represent the average of at least three independent experiments with the re-
spective standard deviation. An asterisk denotes significant differences (P 
0.05) in -Gal Neuro-2A cells containing neurites that were cotransfected
with theORF2 reporter and aNotch1 orNotch3 expression plasmid relative to
-Gal Neuro-2A cells containing neurites after transfection with a plasmid
expressing Notch1 or Notch3 plus the empty vector, as determined by the
Student t test.
FIG 5 ORF2 interferes with Notch-mediated trans activation of the HES5
promoter. Neuro-2A cells were cotransfected with a plasmid containing the
firefly luciferase gene downstreamof theHES5 promoter, a plasmid expressing
the Notch1 (A, C) or Notch3 (B, D) ICD, and increasing amounts of a plasmid
expressing ORF2 (C, D). Promoter activity was measured by using a dual-
luciferase assay. A plasmid expressing Renilla luciferase under the control of a
minimal herpesvirus TK promoter was used as an internal control. The results
are the average of four independent experiments, and the error bars denote the
standard deviation. An asterisk denotes significant differences (P  0.05) in
HES5 promoter activity in Neuro-2A cells following cotransfection with the
ORF2 reporter and a Notch1 or Notch3 expression plasmid relative to HES5
promoter activity following transfection with a plasmid expressing Notch1 or
Notch3 plus the empty vector, as determined by the Student t test.
ORF2 Inhibits Notch-Mediated Signaling
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4-fold, which was significantly different from the empty-vector
control (Fig. 5C). ORF2 also significantly reduced Notch3-medi-
ated trans activation of HES5 promoter activity in a dose-depen-
dent fashion (Fig. 5D).
Additional studies were performed to identify mutant ORF2
constructs that do not interfere with Notch-mediated trans acti-
vation of the HES5 promoter. All of the transposon mutant con-
structs inhibited Notch1 (Fig. 6A)- or Notch3 (Fig. 6B)-mediated
trans activation of the HES5 promoter similarly to WT ORF2. In
contrast, ORF2-NLS, ORF2-P, and ORF2-AP were unable to
significantly interfere with Notch1- or Notch3-mediated trans ac-
tivation of the HES5 promoter compared to the empty vector. In
summary, specific ORF2 sequences were necessary for interfer-
ence with Notch1- or Notch3-mediated trans activation of the
HES5 promoter.
ORF2 promotes Notch3 degradation. Studies were subse-
quently performed to test whether ORF2 influences the steady-
state levels of Notch. The rationale for this study was that the
assembly of a Notch-CSL complex at a promoter leads to recruit-
ment of the cyclin-dependent kinase 8 (CDK8)-cyclin C complex
(48). CDK8-cyclin C phosphorylates Notch, and phosphorylated
Notch is a substrate for the nuclear E3 ubiquitin ligase Sel10. Sel10
interacts with the C-terminal PEST region of Notch, and this is
required for proteasome-dependent degradation. When Notch is
degraded, the coactivator complex dissociates from CSL, leading
to the recruitment of a corepressor complex and repression of
gene expression.
To examine whether ORF2 has an effect on steady-state
Notch3 levels, cotransfection studies were performed and Notch3
protein levels were examined by Western blot analysis. Cells were
also treated with CHX to block de novo protein synthesis to exam-
ine the turnover of steady-state Notch3 protein levels. In the ab-
sence of ORF2, Notch3 levels were reduced within 2 h after CHX
treatment unless the proteasome inhibitor lactacystin was added
to cultures (Fig. 7A). In the presence of ORF2, Notch3 protein
levels were consistently lower than those of the empty-vector con-
trol, even before CHX treatment (Fig. 7A). One hour after CHX
treatment, the levels of Notch3 were also lower in cells cotrans-
fected with ORF2 than in the empty-vector control. An ORF2
frameshift mutant construct (2A/ORF2) that expresses mRNA
(25) but does not express a protein recognized by the Flag mono-
clonal antibody or the ORF2-specific antibody had no effect on
Notch3 stability (Fig. 7B). Even prolonged exposure of the West-
ern blot that was probed with the ORF2-specific antibody did not
reveal a specific band in cells transfected with the 2A/ORF2 con-
struct. In contrast to Notch3, ORF2 had no obvious effect on
steady-state Notch1 protein levels (data not shown).
To identify ORF2 sequences that influence Notch3 stability,
Neuro-2A cells were cotransfected with the Notch3 expression
plasmid plus the designated mutant ORF2 constructs and West-
ern blot assays were performed to measure Notch protein levels.
Three transposon mutant constructs that did not stimulate
neurite formation (ORF2-134, ORF2-240, and ORF2-271) and
one that behaved like the WT (ORF2-529) were used for these
studies. ORF2-240, but not the other transposon mutant con-
structs, had slightly higher levels of Notch3 than WT ORF2
(Fig. 7C). The ORF2-NLS mutant construct, but not the two
phosphorylation mutant constructs, had little or no effect on
Notch3 protein stability (Fig. 7D). These studies suggested that
ORF2 reduced the half-life ofNotch3 and that nuclear localization
of ORF2 was necessary for this function.
DISCUSSION
In this study, we demonstrated that the expression of ORF2 in
Neuro-2A cells allowed neurite formation to occur in the presence
of activated Notch1 or Notch3. As expected, Notch1 or Notch3
interferes with neurite formation in serum-arrested Neuro-2A
cells (31–34). Although previous studies demonstrated that ORF2
interfered with the ability of Notch1 and Notch3 to activate pro-
ductive infection and trans activate certain viral promoters (26),
they did not address whether ORF2 influences Notch-mediated
signaling in the context of known cellular functions. It now seems
clear that, in general, ORF2 interferes with Notch-mediated sig-
naling. Activated Notch is required for the growth of certain hu-
man tumors (49–51), suggesting that ORF2may have therapeutic
value with respect to inhibition of the growth of tumors that are
dependent on Notch for proliferation.
Many other genes, in addition to Notch, negatively regulate
neurite sprouting. These include A1 adenosine receptor, merlin,
FIG 6 Localization of ORF2 sequences important for Notch-mediated trans
activation of the HES5 promoter. Neuro-2A cells were cotransfected with a
plasmid expressing the Notch1 or Notch3 ICD, a plasmid expressing WT or
mutantORF2, and a plasmid containing the firefly luciferase gene downstream
of the HES5 promoter. Luciferase assay was performed as described in the
legend to Fig. 5. The results are the average of three independent experiments,
and the error bar denotes the standard deviation. Asterisks denote significant
differences (P 0.05) in HES5 promoter activity in Neuro-2A cells following
cotransfection with the ORF2 reporter and a Notch1 or Notch3 expression
plasmid relative to HES5 promoter activity following transfection with a plas-
mid expressing Notch1 or Notch3 plus the empty vector, as determined by the
Student t test.
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adenomatous polyposis coli protein, -catenin, Cdc42-interact-
ing protein 4, harmine, HES-1, HES-5, proline/serine-rich coiled-
coil protein 1 (also known asDDA3), andVanGogh 1 (47, 52–59).
Conversely, a number of genes promote neurite sprouting. For
example, a complex containing diacylglycerol kinase , Rac1, and
syntrophin promotes neurite outgrowth (60, 61). In addition, the
Brn-3a transcription factor, CD47 (also referred to as integrin-
associated protein), degenerin/epithelial Na channel protein,
Dickkopf-1, insulin-like growth factors I and II,NF-B, plasticity-
related gene 5, the Prickle 1 or 2 gene, protruding, retina-derived
growth factor, and Wnt-3a promote neurite outgrowth (62–71).
Several proteins that positively or negatively regulate neurite out-
growth belong to the Wnt signaling pathway (adenomatous
polyposis coli protein, -catenin, Wnt-3a, and Dickkopf-1). The
Wnt and Notch signaling pathways have considerable cross talk,
and thus, activation or repression of the Notch signaling pathway
impacts Wnt signaling (72, 73). It is not clear whether ORF2 in-
fluences theWnt signaling pathway and/or other genes that regu-
late neurite outgrowth.
In general, there was a correlation between the abilities of the
respective mutant ORF2 constructs to inhibit neurite formation,
the bICP0 early promoter (44), BHV-1 productive infection (44),
and Notch-mediated trans activation of the HES-5 promoter
(Table 1 contains a summary of the results for the respective mu-
tant constructs). The ability of four transposon mutant ORF2
constructs (ORF2-95, ORF2-134, ORF2-240, and ORF2-271) to
enhance the degradation of Notch3 did not correlate with neurite
formation, activation of productive BHV-1 infection, and activa-
tion of BHV-1 promoters, suggesting that sufficient levels of
Notch3 were present to perform these functions. Because of the
FIG 7 ORF2 reduces the steady-state levels of Notch3. (A) Neuro-2A cells were transfected with the designated plasmids and then collected and processed for
Western blot analysis. Cultures were treated with 100 M CHX for 1 or 2 h at 40 h after transfection. To inhibit proteasome activity, cells were treated with
lactacystin (15 M) 10 h prior to CHX treatment. (B) The 2A/ORF2 plasmid contains ORF2 cloned such that there is a one-nucleotide frameshift downstream
of the N-terminal Flag epitope. The 2B/ORF2 plasmid contains ORF2 in frame with the N-terminal Flag epitope. The Western blots were probed with a
Flag-specific monoclonal antibody or an ORF2-specific peptide antibody. (C, D) The effects of the respective mutant ORF2 constructs on steady-state Notch3
protein levels were examined. Neuro-2A cells were cotransfected with ORF2 or the designated mutant ORF2 constructs and a plasmid expressing Notch3.
Cultures were treated with CHX as described above. A mouse anti-Flag antibody was used to detect WT and mutant ORF2, while Notch3 was detected by using
a rabbit anti-Notch3 antibody.-Actin protein levels were determined to confirm that equal amounts of protein were loaded in each lane. Themolecular weights
(103) of the respective bands are shown to the left of each Western blot.
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complexity of the regulation of neurite formation, it is also possi-
ble that ORF2 inhibits other cellular proteins that interfere with
neurite formation. Interestingly, two phosphorylation mutant
constructs (ORF2-P and ORF2-AP) did not effectively inhibit
Notch-mediated trans activation of the HES5 promoter, whereas
the same mutant constructs promoted neurite formation and in-
hibited Notch1-mediated trans activation of the bICP0 early pro-
moter with WT efficiency (44). For activated Notch to stimulate
transcription, Notch, CSL, and MAMLmust form a complex at a
consensus CSL binding site (reviewed in references 27 and 29).
Consequently, ORF2 may (i) interfere with the formation of the
Notch-CSL-MAML complex, (ii) prevent the Notch-CSL-MAML
complex from interacting with certain CSL consensus binding
sites, or (iii) interfere with certain coactivators recruited to the
Notch-CSL-MAML complex (27, 29). Reduction of the steady-
state levels of Notch3 by ORF2 would also interfere with the trans
activation potential of Notch3. We speculate that ORF2 phos-
phorylation influences trans activation of the bICP0 early pro-
moter but not the HES5 promoter because Notch-mediated trans
activation requires the formation of different complexes on these
two promoters. The ORF2 phosphorylation mutant constructs
are more stable than ORF2 (44), suggesting that the differential
effects of inhibiting Notch-mediated trans activation were not
merely due to lower levels of mutant ORF2 in transfected cells.
Considering the complexity of Notch-mediated transcriptional
activation and neurite sprouting, it is not surprising that different
mutant ORF2 constructs may affect one process but not others.
On the basis of our present studies, we believe that ORF2 interfer-
ence with Notch3 functions is mediated by the ability of ORF2 to
interact with Notch3, sequester it to the rim of the nucleus (26),
and enhance Notch3 degradation.
ORF2, in the absence of other viral gene products, inhibits
apoptosis (25, 70) in transiently transfected cells. The antiapopto-
sis functions of ORF2 are believed to be crucial for the latency-
reactivation cycle because an LR mutant virus that contains stop
codons at the amino terminus of ORF2 induces higher levels of
apoptosis in TG neurons during the establishment of latency (22)
and is not reactivated from latency after DEX treatment (6). ORF2
promotion of neurite formation in the presence of Notch may
maintain normal neuronal functions, including neuronal sur-
vival, after infection. Productive BHV-1 infection induces Notch1
protein levels (26), suggesting that during the establishment of
latency, ORF2 maintains axonal projections in infected neurons
by promoting neurite sprouting in the presence of activated
Notch. In the absence ofORF2 (LRmutant virus, for example), we
predict that certain infected neurons are more susceptible to loss
of axonal projections because activated Notch is present. It is well
established that neurons with damaged or cut axons can undergo
Wallerian degeneration, a slow form of neuronal death (36, 74).
The fact that Notch stimulates productive infection (26) also fa-
vors virus-induced neuronal cell death. In neuronal progenitor
cells, Notch activation induces apoptosis by a p53-dependent
pathway (38). Collectively, these observations suggest that the
ability of ORF2 to restrain Notch functions complements the
antiapoptosis functions of ORF2 to promote the establishment
and life-long maintenance of latency.
During DEX-induced reactivation from latency, Notch3 RNA
(26), as well as protein, levels are increased in TG, andHES6 RNA
levels are increased during reactivation from latency (43). Exam-
ination of DEX-induced transcription in TG of calves latently in-
fected with BHV-1 revealed that many genes activated by Notch
signaling are induced (data not shown), suggesting that the Notch
signaling pathway may enhance reactivation from latency. Since
ORF2 protein expression is reduced during DEX-induced reacti-
vation,we predict that activatedNotch familymemberswould not
be restrained by ORF2, suggesting that activated Notch destabi-
lizes normal neuronal functions and may induce neuronal cell
death, as well as reactivation from latency.
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